The prognostic value of global longitudinal strain in patients with AL amyloidosis with cardiac involvement treated with up-front daratumumab, cyclophosphamide, bortezomib and dexamethasone

20 June 2026 (13:15 - 14:15)
Organised by: Logo
Congress Presentation Part of: Research in cancer therapy-related cardiovascular toxicity: from bench to bedside Cancer Biology and Treatment Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology